-
2024-519655-28-00
5
2026-04-23
Premenopausal patients with high-risk HR-positive/HER2-negative breast
-
2024-514006-31-00
9
2026-04-16
Non-active Progressive Multiple Sclerosis (PMS)
-
2024-519818-31-01
5
2026-04-10
Endometrial Cancer
Advanced, Recurrent, Metastatic, or Primary Unresec
-
2025-521884-12-00
5
2026-03-19
First line triple-negative breast cancer (TNBC)
-
2024-513911-28-00
10
2026-03-04
Acute Ischemic Stroke
-
2024-512714-18-00
9
2025-11-11
Relapsing Multiple Sclerosis
-
2024-516525-31-01
5
2025-07-14
Primary Biliary Cholangitis
-
2023-505172-29-00
4
2025-04-24
Resectable Non-small Cell Lung Cancer
-
2024-511900-17-00
3
2025-02-14
Oncology: RELAPSED PRIMARY CNS LYMPHOMA
-
2024-514799-42-00
4
2024-11-05
IDIOPATHIC PULMONARY FIBROSIS
-
2023-504231-41-01
4
2024-10-02
Locally advanced or metastatic urothelial cancer
-
2024-516163-88-00
11
2024-08-01
Acute ischemic stroke
-
2023-508153-12-00
5
2024-03-26
Hospital-acquired pneumonia
-
2024-518019-20-00
4
2021-10-19
La population concernée est celle des patients hospitalisés en réanima
-
2024-513292-40-00
5
2026-06-15
Multiple sclerosis
-
2025-522687-33-00
5
2026-05-19
Stroke
-
2023-505046-26-00
5
2026-05-07
Colon carcinoma
-
2025-521546-23-00
5
2026-04-21
Secondary progressive multiple sclerosis
-
2024-517674-23-00
5
2026-04-09
Subjects undergoing elective endovascular coiling-only repair of unrup
-
2025-521636-10-00
4
2026-02-04
Progressive Forms of Multiple Sclerosis (PMS)
-
2024-517136-21-00
5
2025-12-05
Renal Cell Carcinoma
-
2025-520747-32-00
5
2025-10-29
Mild to moderate Alzheimer’s Disease
-
2023-503283-17-00
6
2025-10-22
Women who delivered by caesarean and have a moderate postpartum iron d
-
2024-520413-53-00
5
2025-10-21
Spinocerebellar ataxia